Report Scope & Overview:
Blood Glucose Monitoring Device Market Size was valued at USD 12.54 billion in 2022, and expected to reach USD 23.05 billion by 2030, and grow at a CAGR of 7.9% over the forecast period 2023-2030. The development of diabetes patients is driving more interest for the blood glucose monitoring . A self-monitoring device assists patients with checking blood glucose levels without anyone else. There is an assortment of parts on the lookout. Glucometers, lancets and test strips are essential assortments on the lookout. There are a lot of elements that cause diabetes in patients. Corpulence prompts type 2 diabetes. The unfortunate way of life and sedimentary way of life of individuals is expanding glucose levels.
To get more information on Blood Glucose Monitoring Device Market - Request Sample Report
The general glucose monitoring is innovation situated. A gadget could assist with recognizing hypo and hyperglycemic conditions. In the forcast period , the blood glucose monotoring device will have good circumstances. The home setting section of the market is seeing high benefits. Through home testing, the patients have some control over glucose levels effectively. Assuming the glucose level is high visiting medical clinics for additional therapy is simple with the gadgets. The element of any blood glucose monition system is sensors, transmitters and screens. These highlights and advantages of the gadgets will prompt gigantic market advancements.
Market Dynamics
Drivers
Realizing exact glucose levels in the blood is easy.
Recognition of diabetes.
Increasing demand in the market.
Restraints
Lower analysis.
Deferring the treatment for the sickness.
Awerness to the framework.
Opportunities
Simple access of these monitoring device will prompt.
The government drives to help preventive consideration.
clinical gadgets accessible from home.
Challenges
The low repayment approaches.
Many patients don't have an idea how to use it.
The High price of the device.
Impact of COVID-19
The COVID-19 pandemic has opened new open doors for blood glucose monitoring devices and these devices acquired fame in the diabetic consideration market. Mindfulness with respect to the advantages of blood glucose monitoring devices expanded among the buyers as, during the pandemic, there had been an accentuation on the utilization of virtual centers and telemedicine for diabetic administration. The blood glucose monitoring device assisted patients and medical services suppliers with improving glycemic control and possibly increment patient self-administration, subsequently changing diabetes care altogether. Further, a flood in the interest for blood glucose monitoring devices because of the fast reaction by significant market players during the Covid-19 pandemic.
Market Estimation
Blood glucose monitoring device market size was esteemed at 12.54 billion out of 2022 and is supposed to extend at a compound annual growth rate (CAGR) of 7.9% from 2022 to 20230. And is supposed to estimate by 23.05 billion by 2030.
Key Market Segments:
By Product
Self-monitoring Devices:
Blood Glucose Meter
Testing Strips
Lancets
Continuous Blood Glucose Monitoring Devices
Sensors
Transmitter & Receiver
Insulin Pumps
By End-use
Hospitals
Home Care
Diagnostic Centers
To Get Customized Report as per your Business Requirement - Request For Customized Report
Key Players
The Key Players are Medtronic plc, Sanofi, Ascensia Diabetes Care, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, Ypsomed Holdings, Novo Nordisk, Glysens Incorporated, F. Hoffmann-La Roche Ltd and Others
Regional Analysis
North America gained a significant portion of itself observing the blood glucose gadgets market, inferable from high-frequency pace of diabetes in the locale. Also, the presence of vital participants in the area supplements the development of the market. In any case, Asia-Pacific is supposed to develop at the quickest rate during the figure time frame, because of the expansion in the pervasiveness pace of diabetes in the area. Furthermore, the nations in the district like India and China, have the most elevated populace base, which is undiscovered with diabetes. Moreover, the continually advancing medical services industry drives the development of the market in creating economies.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Report Attributes | Details |
---|---|
Market Size in 2022 | US$ 12.54 Billion |
Market Size by 2030 | US$ 23.05 Billion |
CAGR | CAGR of 7.9% From 2023 to 2030 |
Base Year | 2022 |
Forecast Period | 2023-2030 |
Historical Data | 2020-2021 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Product (Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices) • By End-Use (Hospitals, Home Care, Diagnostic Centers) |
Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Company Profiles | Medtronic plc, Sanofi, Ascensia Diabetes Care, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, Ypsomed Holdings, Novo Nordisk, Glysens Incorporated, F. Hoffmann-La Roche Ltd. |
DRIVING FACTORS | • Realizing exact glucose levels in the blood is easy. • Recognition of diabetes. • Increasing demand in the market. |
Restraints | • Lower analysis. • Deferring the treatment for the sickness. • Awerness to the framework. |
Ans: The Blood Glucose Monitoring Device Market Size was valued at USD 12.54 billion in 2022.
Realizing exact glucose levels in the blood is easy.
Recognition of diabetes.
Increasing demand in the market.
Ans: North America is dominate the Blood Glucose Monitoring Device Market.
The low repayment approaches.
Many patients don't have an idea how to use it.
Ans: forecast period of Blood Glucose Monitoring Device Market is 2023-2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global blood glucose monitoring device market Segmentation, by Product Outlook
8.1 Self-monitoring Devices:
8.1.1 Blood Glucose Meter
8.1.2 Testing Strips
8.1.3 Lancets
8.2 Global Continuous Blood Glucose Monitoring Devices:
8.2.1 Sensors
8.2.2 Transmitter & Receiver
8.2.3 Insulin Pumps
9. Global blood glucose monitoring device market Segmentation, by End-use Outlook
9.1 Hospitals
9.2 Home Care
9.3 Diagnostic Centers
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Medtronic plc
11.3 Sanofi
11.4 Ascensia Diabetes Care
11.5 Dexcom, Inc.,
11.6 Insulet Corporation
11.7 Ypsomed Holdings
11.8 Novo Nordisk
11.9 Glysens Incorporated
11.10 F. Hoffmann-La Roche Ltd.
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
13.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Report Scop & Overview: Healthcare Payer Services Market
Report Scope & Overview: Computer Vision in Healthcare Market
Menstrual Cup Market Overview:
Report Scope & Overview: Clinical Decision Support Systems Ma
The Feminine Hygiene Products Market Size was valued at USD 24.1 billion in 2022 and is expected to reach USD 37.26 billion by 2030, and grow at a CAGR of 5.6% over the forecast period 2023-2030.
Report Scope & Overview: The
Hi! Click one of our member below to chat on Phone